Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Tata Nifty MidSmall Healthcare Index Fund | Axis Nifty 500 Index Fund | |
|---|---|---|
| Category | Index Funds (Equity) | Index Funds (Equity) |
| Plan | Regular | Regular |
| Fund house | Tata | Axis |
| AUM | ₹210 Cr | ₹319 Cr |
| NAV | ₹15.6794 | ₹10.3770 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | — | 2.3 years |
| Expense ratio | 1.1% | 1.1% |
| Stars | Not rated | Not rated |
| Growth Score | — | — |
AUM: AMFI's average assets under management for July - September 2026, in ₹ crore, for the whole fund (Direct and Regular, Growth and IDCW added up). The same source and period for every fund, so the figures compare.
Returns
| Tata Nifty MidSmall Healthcare Index Fund | Axis Nifty 500 Index Fund | |
|---|---|---|
| 1 month | — | +9.27% |
| 3 months | — | +2.30% |
| 6 months | — | +6.80% |
| YTD | — | +0.65% |
| 1 year | — | +0.11% |
| 3 years (CAGR) | — | — |
| 5 years (CAGR) | — | — |
| 10 years (CAGR) | — | — |
| Since launch | — | +1.46% |
Risk
| Tata Nifty MidSmall Healthcare Index Fund | Axis Nifty 500 Index Fund | |
|---|---|---|
| Volatility | — | — |
| Downside volatility | — | — |
| Sharpe | — | — |
| Sortino | — | — |
| Calmar | — | — |
| Return / risk | — | — |
| Deepest fall | — | −18.88% |
| Days to recover | — | — |
| Below its high | — | −1.97% |
Against benchmark
| Tata Nifty MidSmall Healthcare Index Fund | Axis Nifty 500 Index Fund | |
|---|---|---|
| Alpha | — | — |
| Beta | — | — |
| R² | — | — |
| Up capture | — | — |
| Down capture | — | — |
| Tracking error | — | — |
| Information ratio | — | — |
| Treynor | — | — |
Consistency
| Tata Nifty MidSmall Healthcare Index Fund | Axis Nifty 500 Index Fund | |
|---|---|---|
| Best 1-year | — | +16.47% |
| Middle 1-year | — | +0.91% |
| Worst 1-year | — | −10.08% |
| 1-year periods with a loss | — | 44.2% |
| Middle 3-year | — | — |
| Positive months | — | — |
| Best day | — | +3.94% |
| Worst day | — | −3.36% |
| Worst 5% day | — | −1.49% |
| Positive days | — | 50.9% |
| NAVs a year | — | 251 |
SIP of ₹10,000 a month
| Tata Nifty MidSmall Healthcare Index Fund | Axis Nifty 500 Index Fund | |
|---|---|---|
| 5-year XIRR | — | — |
| 5-year value | — | — |
| 3-year XIRR | — | — |
| 1-year XIRR | — | +8.34% |
Holdings overlap i
| Tata Nifty MidSmall Healthcare Index Fund | Axis Nifty 500 Index Fund | |
|---|---|---|
| Tata Nifty MidSmall Healthcare Index Fund Regular · filing Oct 2026 | — | 3% |
| Axis Nifty 500 Index Fund Regular · filing Oct 2026 | 3% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Tata Nifty MidSmall Healthcare Index Fund and Axis Nifty 500 Index Fund
Overlap
3.5%
smaller weight of each shared stock, added up
Stocks in common
30
of 30 and 500
Weight in common
100% · 3%
of each fund's money
Filings compared
Oct 2026 · Oct 2026
same month
| Common stock | Tata Nifty MidSmall Healthcare Index Fund | Axis Nifty 500 Index Fund | Counts toward overlap |
|---|---|---|---|
| Laurus Labs Limited | 14.12% | 0.49% | 0.49% |
| Lupin Limited | 7.36% | 0.26% | 0.26% |
| Aurobindo Pharma Limited | 7.00% | 0.24% | 0.24% |
| Fortis Healthcare Limited | 6.03% | 0.21% | 0.21% |
| Glenmark Pharmaceuticals Limited | 5.22% | 0.18% | 0.18% |
| Alkem Laboratories Limited | 4.65% | 0.16% | 0.16% |
| Mankind Pharma Limited | 4.26% | 0.15% | 0.15% |
| IPCA Laboratories Limited | 4.04% | 0.14% | 0.14% |
| Biocon Limited | 3.70% | 0.13% | 0.13% |
| Gland Pharma Limited | 3.72% | 0.13% | 0.13% |
| Sai Life Sciences Limited | 3.25% | 0.11% | 0.11% |
| Acutaas Chemicals Limited | 3.13% | 0.11% | 0.11% |
| Krishna Institute Of Medical Sciences Limited | 2.82% | 0.10% | 0.10% |
| Aster DM Quality Care Limited | 2.74% | 0.10% | 0.10% |
| Neuland Laboratories Limited | 2.56% | 0.09% | 0.09% |
| Piramal Pharma Limited | 2.24% | 0.08% | 0.08% |
| Ajanta Pharma Limited | 2.41% | 0.08% | 0.08% |
| Wockhardt Limited | 2.37% | 0.08% | 0.08% |
| Dr. Lal Path Labs Limited | 2.24% | 0.08% | 0.08% |
| Abbott India Limited | 2.01% | 0.07% | 0.07% |
| Granules India Limited | 1.87% | 0.07% | 0.07% |
| Narayana Hrudayalaya Limited | 1.79% | 0.06% | 0.06% |
| Global Health Limited | 1.70% | 0.06% | 0.06% |
| Onesource Specialty Pharma Limited | 1.85% | 0.06% | 0.06% |
| Anthem Biosciences Limited | 1.35% | 0.05% | 0.05% |
| Glaxosmithkline Pharmaceuticals Limited | 1.56% | 0.05% | 0.05% |
| Cohance Lifesciences Limited | 1.09% | 0.04% | 0.04% |
| Syngene International Limited | 1.15% | 0.04% | 0.04% |
| Natco Pharma Limited | 1.16% | 0.04% | 0.04% |
| Poly Medicure Limited | 0.83% | 0.03% | 0.03% |
| 30 stocks | 100.2% | 3.5% | 3.5% |
Only in Tata Nifty MidSmall Healthcare Index Fund (0)
Every stock it holds is also in the other fund.
Only in Axis Nifty 500 Index Fund (470)
| HDFC Bank Limited | 5.57% |
| ICICI Bank Limited | 5.26% |
| Reliance Industries Limited | 4.09% |
| Bharti Airtel Limited | 3.15% |
| Larsen & Toubro Limited | 2.38% |
| Infosys Limited | 2.20% |
| State Bank of India | 2.09% |
| Axis Bank Limited | 1.84% |
| Kotak Mahindra Bank Limited | 1.78% |
| Bajaj Finance Limited | 1.35% |
| ITC Limited | 1.34% |
| Tata Consultancy Services Limited | 1.34% |
| Mahindra & Mahindra Limited | 1.33% |
| Eternal Limited | 1.31% |
| Sun Pharmaceutical Industries Limited | 0.99% |
| Titan Company Limited | 0.96% |
| Hindustan Unilever Limited | 0.87% |
| NTPC Limited | 0.79% |
| HCL Technologies Limited | 0.79% |
| Maruti Suzuki India Limited | 0.78% |
| Adani Ports and Special Economic Zone Limited | 0.76% |
| BSE Limited | 0.75% |
| Tata Steel Limited | 0.73% |
| Bharat Electronics Limited | 0.70% |
| UltraTech Cement Limited | 0.69% |
and 445 smaller holdings (52.7% of the fund).
Method: from each fund's latest monthly portfolio filing, shares only (Indian and foreign equity; bonds, cash and derivatives are left out). Overlap adds up, for every stock both hold, the smaller of the two weights.
Sectors and company size
| Tata Nifty MidSmall Healthcare Index Fund | Axis Nifty 500 Index Fund | |
|---|---|---|
| Large companies | — | 68.3% |
| Mid companies | 68.2% | 20.5% |
| Small companies | 32.0% | 11.1% |
| Top 10 holdings | 60.1% | 29.7% |
| Largest sector | Pharmaceuticals & Biotechnology 81% | Banks 20% |